Skip to main content

Table 2 Relationship between the CBCS and clinicopathological characteristics in patients undergoing potentially curative resection for gastric cancer

From: Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection

Clinicopathological features

CBCS

P value

0

1

2

Case

824

673

313

 

Age, median (IQR)

59

63

66

< 0.001

Sex

   

< 0.001

 Male

668 (81.1%)

474 (70.4%)

232 (74.1%)

 

 Female

156 (18.9%)

199 (29.6%)

81 (25.9%)

 

BMI, median, (IQR)

22.3

21.9

21.8

0.468

ASA score

   

< 0.001

 1

578 (70.1%)

399 (59.3%)

149 (47.6%)

 

 2

238 (28.9%)

244 (36.3%)

144 (46.0%)

 

 3

8 (1.0%)

30 (4.5%)

20 (6.4%)

 

Tumor location

   

0.001

 Upper

195 (23.7%)

176 (26.2%)

70 (22.4%)

 

 Middle

119 (14.4%)

124 (18.4%)

77 (24.6%)

 

 Lower

405 (49.2%)

290 (43.1%)

120 (38.3%)

 

 Mixed

105 (12.7%)

83 (12.3%)

46 (14.7%)

 

Tumor size (cm), median (IQR)

4.0

4.5

5.0

< 0.001

Histologic type

   

0.725

 Differentiated

159 (19.3%)

141 (21.0%)

62 (19.8%)

 

 Undifferentiated

665 (80.7%)

532 (79.0%)

251 (80.2%)

 

Vascular invasion

   

< 0.001

 Negative

675 (81.9%)

513 (76.2%)

218 (69.6%)

 

 Positive

149 (18.1%)

160 (23.8%)

95 (30.4%)

 

Perineural invasion

   

0.219

 Negative

707 (85.8%)

575 (85.4%)

256 (81.8%)

 

 Positive

117 (14.2%)

98 (14.6%)

57 (18.2%)

 

pTNM stage

   

< 0.001

 I

323 (39.2%)

148 (22.0%)

44 (14.1%)

 

 II

179 (21.7%)

174 (25.9%)

80 (25.6%)

 

 III

322 (39.1%)

351 (52.2%)

189 (60.4%)

Â